+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macrolide Antibiotic"

Pneumonia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 100 Pages
  • Global
From
Antibacterial Drugs - Global Strategic Business Report - Product Thumbnail Image

Antibacterial Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 244 Pages
  • Global
From
Antibiotics - Global Strategic Business Report - Product Thumbnail Image

Antibiotics - Global Strategic Business Report

  • Report
  • August 2025
  • 266 Pages
  • Global
From
Pneumococcal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Typhoid Fever - Pipeline Insight, 2025 - Product Thumbnail Image

Typhoid Fever - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Oral Antibiotics Market 2025-2033 - Product Thumbnail Image

Oral Antibiotics Market 2025-2033

  • Report
  • March 2025
  • 147 Pages
  • Global
From
From
From
50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Syphilis Pipeline Analysis Report 2025 - Product Thumbnail Image

Syphilis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Poultry Antibiotics - Global Strategic Business Report - Product Thumbnail Image

Poultry Antibiotics - Global Strategic Business Report

  • Report
  • August 2025
  • 382 Pages
  • Global
From
Pneumococcal Infections Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Pneumococcal Infections Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Community Acquired Pneumonia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Community Acquired Pneumonia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Bacterial Pneumonia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Bacterial Pneumonia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics. The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more